Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Phosphorus oxychloride | HCID 24813 | — |
| Reactant | (Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid | HCID 2724510 | — |
| Reactant | HCID 131715963 | HCID 131715963 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 131715962 | HCID 131715962 | — |
Reaction Steps
7-Amino-3-[2-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid pivaloyloxymethyl ester (0.229 g) as prepared in Reference Example 1 above was dissolved in methylene chloride (5 ml). The resultant solution was admixed with 2-(2-tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid (syn-isomer) (0.235 g) and methylene chloride (5 ml). To the mixture obtained were further added pyridine (0.07 ml) and then dropwise phosphorus oxychloride (0.07 ml) at -20° C. The reaction mixture was stirred for 10 minutes at 0° C. and poured into a mixture of ice-water (50 ml) and ethyl acetate (50 ml). After stirring, the organic phase was separated from the aqueous phase and washed with ice-wated and then with ice-cooled aqueous saturated sodium hydrogen carbonate solution. The organic phase was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified chromatographically on a column of silica gel (Wako gel C-300) (20 g ) as developed with benzene-ethyl acetate (5:1) as the development solvent. 7-[2-Methoxyimino-2(2-tritylaminothiazol-4yl)acetamido]-3-[2-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid (syn-isomer) pivaloyloxymethyl ester (0.184 g) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04839350 |
|---|
| Source dataset | uspto-grants-1989_06 |
|---|
| ORD ID | ord-166f6598dd8e4a679ebd59ce0c34ee42 |
|---|
| Source note | uspto-grants-1989_06 |
|---|